Vertex Pharmaceuticals
VRTX
VRTX
1,274 hedge funds and large institutions have $81.8B invested in Vertex Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 532 increasing their positions, 457 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
0.98% less ownership
Funds ownership: 92.28% → 91.31% (-0.98%)
2% less capital invested
Capital invested by funds: $83.2B → $81.8B (-$1.4B)
6% less funds holding in top 10
Funds holding in top 10: 33 → 31 (-2)
Holders
1,274
Holding in Top 10
31
Calls
$674M
Puts
$633M
Top Buyers
| 1 | +$224M | |
| 2 | +$178M | |
| 3 | +$137M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$119M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$109M |
Top Sellers
| 1 | -$359M | |
| 2 | -$182M | |
| 3 | -$170M | |
| 4 |
Man Group
London,
United Kingdom
|
-$134M |
| 5 |
State Street
Boston,
Massachusetts
|
-$102M |